Vistagen Therapeutics, Inc. is a biopharmaceutical entity in the study of mental wellbeing. Operating in the US, Vistagen aims to help with mental health issues worldwide such as depressive and anxiety disorders.
In the bustling biotechnology sector, Vistagen Therapeutics delves into transdisciplinary studies to assist mental health issues. As a stand-alone organisation, Vistagen uses techniques to develop medications that fill the gaps left by traditional treatments for depression and anxiety disorders. Vistagen has a vast array of programs focused on anxiety, depression, suicidal ideation, and neuropathic pain.
Learn more about the share price performance of VTGN on eToro.